Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Hi Ginandmilk,
They will issue ADRs in US, they can bundel 5, 10 or 15 of TRX stock in to 1 ADR, so lets say we grow to a SP of 2p, then the company does a consolidation of 1:100, making the SP £2, then you can bundel 5x of these in to 1 ADR and list at NASDAQ for £10/ADR.
Best
Simple answer Ibiza28 is that the TRX is currently under valued... 5x sales, which is the norm, is 0.92p for 13M sales.. still under fair value.. you can calculate the future growth... conservative 17M in 2021 will be 1.2p SP...... top end estimate of 22M sales (70% Y/Y growth predicted by the analysts) is 1.56p.. so IMO we are just starting to take off..
He sounds like a novice Ginandmilk, anybody with the subject knowledge can tell he has no clue about the intricacies of the wound healing process and the role played by the tissue matrix. The key for our products gaining traction is their low rate of rejection by the host along with improved life quality post surgery compared to synthetic materials.
Hi Ginandmilk,
He actually talked about our TRX and displayed the logo and charts!
However, this being a public board probably I shouldn't paint the devil on the wall.. You are right, time for a strong brew (personally a coffee man)
Ta!
Phew.. I was dreading that this will destroy the stock... Its company's/LTHs money that will be robbed from this pump and dump schemes.. it's akin to pillegeing a city.. leaves the residents and the rules empty and some may never recover... If it happens the company will not be able to raise money in the future at the right valuation.. I am hopeful that the IIs and BOD have mechanisms to fight this raid (if ever materialises) and future such raids..
So many probabilities floating in my head that could explain this new found love for TRX, but until I read the RNS on Monday (I don't think they can keep it out longer without explaining the reason for this raise), I will keep to fundamentals i.e we were massively undervalued during the placing, so it is but natural to recover to true value - nonetheless, timing of this raise is curious!!
Gnandmilk.... We don't value biotech/Medtech as much as the peeps on the other side of the pond do!! If we get placed on the NASDAQ, your 50p target is achievable in under 3 years IMO!!!! If that happiness, I will join you in the millionair club!
I agree Ginandmilk and Ohmni, Sp of 5p, however fascinating it is, is still a few quarters away IMO. Many things have to fall in place like:
1) covid receding,
2) Aggressive sales to capture a bigger share of the pent-up demand - this could carve out a bigger, sustainable market share for us, which could easily snowball into something very big in 2-3 years.
3) Good feedback for the products that we are doing for J&J (?) - This could also lead to expansion of the product line.
Lets hope the Bod exceeds our expectation!
Looking at the trading patterns of yesterday and today (trades were done over the asking price pushing the price up!), We could be on to something soon!!
Hi Ginandmilk, your wish has been granted by the looks of it!!
Hi Chester18, .92p is indeed sensible for this share, it will just be 5x sales, 13Mx5=62M Mcap i.e .924p, so it is not out of reach. Mcap of 5x sales is the average for biotech/medtech companies.
Waiting for the trading update and may be some golden nuggets of information!!
Best
Hi Ginandmilk,
My research also lead to J&J (through DePuy Synthes) as our White label deal partner, infact they do mention that 'DoD' is indeed processed by 'cellright technologies' in their demo video(https://www.jnjmedicaldevices.com/en-US/product/dermis-demand-allograft). We all know who owns 'cellright technologies'!!
I didn't want to mention this before as I feared it would be seen as a 'ramp' but my valuation and SP estimates I put forward to 'Chester18' were based on the assumption of this news coming out by H2-2021 through an RNS by the company. We should also then get some sales numbers from this product and hopefully as mentioned in the TRX annual report, they could announce a 'Major expansion' of their product line with J&J.
IMO, only with some clear guidance through RNS on this deal will allow us to make meaningful growth estimates and SP predictions for post 2021.
Best
Hi MrIndia,
We are expecting it around 22nd Jan but nothing is confirmed yet.
I was able to sell 100K easily. That tells me there is good buying pressure, which is always a good sign for near term SP movement.
IMO, the MMs are filling a big order around 0.57-0.58p. But I have to say, IMO the company is in the process of rebuilding its register with a new set of LTHs, so it's hard to predict/understand these near term SP fluctuations.
Best
Hi Chester18,
Thank you for keeping this BB lively and stimulating useful discussions.
More than happy to donate £100 to CRUK, when the SP hits 2.5p, I will be crying with joy when that day arrives!!
Ta
Hi Mafuta
As I said, I am not at all worried, maybe I didn't phrase it well. I meant it doesn't really matter as we are seeing buying at these levels from IIs, so quite the opposite. I was merely pointing to a glaring 4% hole from yesterday's trading, a missing part of the puzzle, which hopefully gets filled soon.
Good news indeed, that too in the region of 0.44p, tells me the current range of the fair price (~0.55p, 20% discount for IIs will land it at 0.44p). More importantly, the confidence on the near/mid term prospects for TRX.
We are still waiting to here about another 4% of the holdings (if we think 6% was sold yesterday), hopefully we will get it by Tuesday but I am worried, just good to know about all the big players in the play.
After doing a bit of number crunching, here is the summary of today's trades:
Potential sells: 475,289,299 (Avg. price - 0.4126p); of these 231,106,321 (Avg. price - 0.4242p) are 'LRGS' trades reported late to the market
Potential buys: 301,694,065 (Avg. price - 0.4424p)
So there are hopefully more buys to come (~175M) tomorrow, in any case at 300M, if it is a new II who bought the shares, they have crossed 3% and have to report it when they have reached their final position.
You're right Chester18, the volume sold is more than double of what Spredex had, so will be curious to see where the rest of the volume came from. Makes me rethink about the raise we had to 0.6p recently, which could have prompted some sells from recent buyers at 0.25p.
It will be positive to see the new director, Brian Phillips, contributing by bringing in LTHs and IIs to this company. I might be jumping the gun here, but It will be interesting to see if the new II has any connection with Brian Phillips.